Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$155,744,518
-$43,867,468 QoQ
Shares Held
4,288,120
0.0% QoQ
Ownership
4.07%
of shares outstanding
% of Portfolio
6.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EcoR1 Capital, LLC holds $2,284,236,973 across 26 Biotechnology names. CRNX ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
|
22,970,388 | $575,178,515 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $437,030,013 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,706,469 | $322,607,964 | |
| 4 | CNTA |
Centessa Pharmaceuticals plc
|
6,000,000 | $238,320,000 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
4,288,120 | $155,744,518 | |
| 6 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $86,309,750 | |
| 7 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $85,245,229 | |
| 8 | CGON |
CG Oncology, Inc.
|
1,102,000 | $74,583,360 |
All Filings in CRNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $155,744,518 | 4,288,120 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $199,611,986 | 4,288,120 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $178,600,198 | 4,288,120 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $123,326,331 | 4,288,120 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $143,823,544 | 4,288,120 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $219,251,575 | 4,288,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $219,122,932 | 4,288,120 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $186,119,246 | 4,155,375 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $194,513,103 | 4,155,375 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $71,605,354 | 2,012,517 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,510,021 | 1,530,263 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,971,339 | 1,330,263 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,364,023 | 1,330,263 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,343,812 | 1,330,263 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,126,365 | 1,330,263 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,809,404 | 1,330,263 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,345,087 | 790,209 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,766,701 | 590,169 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $15,063,731 | 859,802 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,145,000 | 350,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||